Home > Press > 'Nanoshells' simultaneously detect and destroy cancerous cells
Abstract:
Rice Study Indicates Single Particle Can Both Find And Destroy Breast Cancer Cells
Rice researchers have developed a new approach to
fighting cancer that aims to both detect and destroy cancerous cells using
the same, targeted nanoparticles. The research is described in the April 13
issue of the American Chemical Society's journal Nano Letters.
Current molecular imaging approaches solve only the detection half of the
cancer management problem, said lead researchers Jennifer West, the Isabel
C. Cameron Professor of Bioengineering, professor of chemical and
biomolecular engineering and director of the Institute of Biosciences and
Bioengineering, and Rebekah Drezek, the Stanley C. Moore Assistant Professor
of Bioengineering and assistant professor of electrical and computer
engineering.
"You can look for a molecular marker that may indicate a significant
clinical problem, but you can't do anything about it," Drezek said. "We
don't want to simply find the cancerous cells. We would like to locate the
cells, be able to make a rational choice about whether they need to be
destroyed, and if so, proceed immediately to treatment. Ultimately, we want
to provide a comprehensive 'see and treat' approach to cancer care."
To this end, Drezek and West developed a new optically-based imaging and
treatment method based on metal nanoshells spheres measuring just a few
nanometers, or billionths of a meter in diameter. Invented by Naomi Halas,
the Stanley C. Moore Professor of Electrical and Computer Engineering and
professor of chemistry, nanoshells consist of a silica core coated with a
thin layer of gold. Because of their size, nanoshells are subject to the
strange and counterintuitive forces of quantum mechanics, and as a result,
they interact with light in unique ways. They scatter and absorb light of
particular colors, and by varying the diameter of the core and the shell,
researchers can "tune" the shells to react to a specific wavelength of
light.
In this study, the strong scattering of light by nanoshells provides the
optical signal used to detect the cancer cells. West and Drezek's research
team attached an antibody to the nanohells that binds with a protein that's
commonly found on the surface of breast carcinoma cells and not on healthy
cells. In this way, doctors can shine a harmless, non-visible beam of light
through a patient¹s body and "light up" the location of breast cancer cells
The technique can be readily extended to target other types of cancer or
disease processes that have known surface markers.
In prior studies, West and Halas have shown that nanoshells can be made to
absorb light, convert it to heat and destroy cancer tumors.
"With nanoshells, we have the unique ability to engineer particles in which
both the optical scattering and the absorption peaks occur in the
near-infrared (NIR) part of the spectrum," West said. "That's the spectral
region where light best penetrates tissue, and because NIR light is also
completely harmless to normal tissue, this method opens the door for a
non-surgical means of both imaging and treating cancer."
The new approach has some significant advantages over other alternatives
that are under development. For example, optical imaging is much faster and
less expensive than other medical imaging modalities. And while nanoparticle
contrast agents are being developed for use with such technologies as
computed tomography, or CT scans, and magnetic resonance imaging, or MRI,
gold nanoparticles are regarded as more biocompatible than other types of
optically active nanoparticles, such as quantum dots.
Gold is a chemically inert material well-known for its biocompatibility,
which is why it has found use in a variety of medical applications in the
past.
"There is a prior history of the use of gold inside the body that makes the
safety issues somewhat easier to address," Drezek said.
Any new technology requires extensive safety assessment before coming to
market. Nanospectra Biosciences Inc., a Houston-based company that is
commercializing nanoshells technology, has conducted initial evaluations of
nanoshells and found no ill effects.
About Rice University
Rice University is consistently ranked one of America¹s best teaching and
research universities. It is distinguished by its: size: 2,850 undergraduates
and 1,950 graduate students; selectivity: 10 applicants for each place in the
freshman class; resources: an undergraduate student-to-faculty ratio of
6-to-1, and the fifth largest endowment per student among American
universities; residential college system, which builds communities that are
both close-knit and diverse; and collaborative culture, which crosses
disciplines, integrates teaching and research, and intermingles
undergraduate and graduate work. Rice's wooded campus is located in the
nation's fourth largest city and on America's South Coast.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Related News Press |
Possible Futures
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Nanomedicine
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Unveiling the power of hot carriers in plasmonic nanostructures August 16th, 2024
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||